michelcarroll/llama2-earnings-stock-prediction-fine-tune huggingface dataset:
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I think we agree with all your statements David, except that we will stop short of giving guidance for 2023. I would just add that packaging is actually getting strong and stronger and he is even better than what we thought it would be both on volumes, but certainly on the pricing. So, that's very helpful. So as we said a number of times, we were ahead in every in every respect. On the business side. Right. The markets are good. Our position in the markets with strengthening automotive is strong can sheet is strong specialties and super strong aerospace is still an unknown as you point out in our cost performance is excellent doesn't see it and we're very committed to keeping flow. So, we still like the 700 million target for will stop short of setting exactly when it happen.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
John, on iscalimab?

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So I think I'll answer the last question first. I would say closer to 2019, and necessarily, in the middle, I think we've got some good tailwinds going into '21. And that goes to your first question, which is our existing set of assets with the additional cost savings that we're executing on and some other things we're doing, just from an efficiency standpoint, should allow us to see 60%-plus in gross margins going further. However, to get up into a kind of mid-60 range, that would require a little bit of a change in the portfolio, either through M&A or perhaps looking at some SKU rationalization, that doesn't make sense for us going forward. We are actually doing that with -- in our restructuring. Part of our restructuring is shuttering our plant in France. We had negative gross margins associated with that plant. So those are the types of things that we will continue to do and execute on that in the fourth quarter. But we absolutely have a portfolio that should produce 60%-plus gross margins in a normalized environment. But to get to those mid-60 ranges, there's some other portfolio shifts that would have to occur likely through M&A.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you. Good afternoon, and congrats on the strong results and the guidance, guys. Tomer, I have a product-related question. Your Singularity platform is being integrated with Microsoft Azure Active Directory, where SentinelOne provides endpoint and identity solutions, and correct me if I'm wrong, under your conditional policy solution.
So, should I be looking at this integration as Microsoft potentially cannibalizing its own Defender platform in the long term? Can you maybe double-click on that specific integration?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Maybe I'll take -- go ahead, Dan.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes, no -- but I'd note it's also been 13 basis points so far in Q1. So...

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Hey everyone, thanks for the time. So yes, you made a lot of new route announcements. I'm just trying to get a sense for how you're thinking about planning 2022 and 2023. It just seems you're going to have, with growth kind of resuming, it seems like you're going to have an elevated new market as a percent of total.
So just curious how you're thinking about balancing that in 2022 and 2023 specifically? I know you're not -- nothing's announced yet, but just how you're thinking about planning for that going forward?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It is a, building, let's say, 100 billion transistors on one chip versus four, to give an example, isn't equivalent test time. The four chip version is likely to, these are going to be rough rules of thumb, but let's say, 25% more test intensive than the single chip design because there's a premium on sort of known good die testing to, when you put those together in an advanced package. And then the advanced package itself has more potential defect failure modes that need to be tested. So that's one thing around the whole chiplet, multi chip package thing. The other thing, though, that's happening, and this is really going to become prevalent at three nanometer and beyond is the move from FinFET to gate all around transistor architectures. And if you remember, when the world moved from planar to FinFET, it was back in 2012, '13, '14 era, that drove, if you go back and look at the history of sort of the test market, that drove incremental test intensity and complexity in the market. And we're headed for another one of those with gate all around. There's going to be new defect modes, new kind of test intensity boosts coming from this new architecture on the transistor. So even at equivalent transistor counts, we're going to see a little bit more test intensity because of that. So these two trends of chiplets and gate all around and three nanometer, that's probably all the 2023 and beyond story given where three nanometer is right now, but it's coming.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
[Indecipherable] Sure.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Take care, Adrienne.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Great question, Neil. And to clear the record, yes, we have been engaged in M&A for consistently, we just found everything too expensive, particularly in renewables and particularly with all the capital with apparently very low cost of capital chasing some of these transactions. And so, yes, we feel very comfortable pursuing these opportunities organically. You step back and look at the company's capabilities, our assets, our global footprint, our fantastic engineers that are super creative, our deep expertise in materials, metallurgy, robotics, digital, I mean, you name it. We think we've got the toolkit here to pursue these things organically and launch with a few steps ahead of competition in many of these areas. And so yes, that's the plan.
We have made a couple of small investments. We've talked in the past about our investment in a land wind tower manufacturing technology that we're -- we've brought a lot of those skills that I just referenced to bear on helping them achieve their strategic goals and are pretty excited about that. And we've also developed complementary products, specifically a mobile tower crane lifting system for that technology that we'll be bringing to market in early 2022. But yes, I'm pretty excited about -- I feel pretty good about being able to move forward organically, mostly. But nevertheless, I just want to be clear, we're always looking, always looking on the acquisition side for opportunities to strengthen what we do both in the energy transition space as well as our traditional oil and gas space, which we continue to invest in organically as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you to all who joined us today. We appreciate your continued interest in ATI. This concludes our first quarter 2021 conference call.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
So, Kevin, why don't I take a little of this. I'll let David add anything that he thinks, I didn't put in that I should have said. So we are very pleased with the strong results that we're seeing in the US. And that is a result of a lot of hard work by our team. And a lot of it is just blocking and tackling, making sure that we're getting the right inventory, the right price to the right marketing, presenting the right offer to the customer at the right time and doing a bunch of things that we've been doing for so long in terms of improving conversion, lot of A/B testing, all the things we've always done blocking and tackling. There's no silver bullet, there is no sense of this as the magic key to unlock extra demand in the US. It's just a lot of very good work.
Now in terms of alternative accommodations, talked a little bit about how we're pleased to getting more inventory there. We're pleased with gaining some share with some of our professional managers, that's going well. But overall, it's everything that we do to improve our business, provide a better service to both sides of that marketplace, both the customers, giving a great offer and working with all of our suppliers from the biggest international chains to the small alternative accommodation, everything in between to make sure we're providing them with the demand they need to make their business successful.
David, anything specific beyond to add to that?

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It's too early to tell, you know, what the average dose is going to be. We'll be monitoring that, though, throughout the study. But no, there's no minimum. And, you know, we instruct patients they don't have to take it every day.
And, you know, and that's the beauty of this drug is that, you know, they only take it when they need it. I mean, they may go several days and not, you know, encounter a social stressor. So, in those days, there's no need to take it. But then another day, they may have a very stressful day and they may need to take it two or three times that day.
So, there's no minimum, there is a maximum of four based on our tox work but no minimum. And we will be monitoring this through the app regularly, but I don't have any data to share with you right now.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Patrick. I think there's a few other things. As we mentioned, we do have a lot of cost-reduction programs, both in the materials side and the factory efficiency, that we saw some of that benefit coming in nicely in Q4. We'll continue to see that as we go into 2021.
We also talked about the plastics business and rightsizing that with the announcements of our Union City facility. That facility will be kind of closed up in the first quarter, so that should help us a little bit. And as Jeff mentioned, continued progress in market share on the components business, both in weldment precision machining, for seeing those wins. They're starting to show up in the numbers.
I think that should accelerate as we go through 2021. And I think, in addition to the volume you mentioned, just keeping an eye on our expenses and getting that volume leverage as it comes through is key. And then with the healthy outlook in the business, we're pretty bullish on this year.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. Thanks, Sean.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
All right, thank you.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
The rate of bookings, I believe, is going to stay relatively steady. So if we would look at our rate year-to-date on bookings, then it looks like that stays relatively steady. Unlike normally, about this time of year, we see a decline in bookings rate. But at this point in time, we've not seen a decline in bookings rate and the pipeline is telling us it's going to remain at this steady rate.

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Great. Thanks for taking the question. Just want to touch on what you're seeing on the sales side and how rep productivity has been trending this year? And then on top of that, how you're seeing the current and hiring environment to bring in new reps at this point?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks. Good afternoon. Terren, the expansion you mentioned just signing for a couple of populations that now just needs to be signed by the state. Can you give us a sense of the incremental or annualized revenue that should contribute? And then on the guidance, you had bucketed the $100 million into $88 million of under contract or signing phase and $12 million in go-get.
This expansion, was that part of the go-get? Or was that part of the -- what was being contemplated in the $88 million?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, good morning. I wanted to follow up on Jamie's question about Baltimore and investors tend to take markets with a broad brush and not necessarily breaking into submarkets. And I think, at best, Baltimore is, I thought, is neutral. And I'm just wondering how much more capital you could see putting into the market?

    Prediction (one of UP, DOWN, SAME): UP
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So if you look at -- I think I'll start with your question just around the gross profit for our total company. The guide was that we expect that to be up 100 to 120 basis points. And so that's really being driven by a little bit of the conversation we just had. Achieving price/cost neutrality, we're slightly above neutrality through the first half. But we think that we're going to maintain that and be neutral for the full year. And we believe that because of the pricing actions, as D.G. noted, that we expect to continue to take. Our cost rigor with our supply base gives us confidence in what we've been able to do up to this point this year. And as it relates to SG&A, the range of $805 million to $815 million is pretty solid in our minds on a go-forward basis, and it looks similar for Q4.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
I mean, the trajectory of growth has remained consistent. So I think you can look backwards and anticipate, what we'll see going forward with these folks. We're certainly not seeing a slowdown in their ability to ramp up.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Yes. So, we have about 70 projects today. We've got a dozen or more in-flight of additional projects. Today, those projects, as you know, are from a mix of some pure electricity. Some are more high BTU ones. And as we go forward, we're looking at those to capture the RINs opportunity.
As our primary model, historically has been to work with partners on the development. We think that just gets us there faster, right? It also certainly, we don't get all the upside of the room pricing, but it also helps us kind of manage the volatility of that. So, it's more of a royalty model going forward. And again, we're always looking at the model, and we've pursued some of those on our own.
But I think our predominant model going forward will be working with working with third parties, and we don't think we're done at a dozen. Those are just the ones we have right in front of us now, right? We're going through more of our medium-sized landfills, and we think there's other opportunities to unlock there going forward as well.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thanks, Vijay. April, we'll take our next question, please.

    Prediction (one of UP, DOWN, SAME): DOWN
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Sure. For 2021, our focus remains on companion animal. We're very pleased with our progress on placements, which is a really good leading indicator of usage. As you saw, we had double-digit consumable growth as well, which we're quite pleased with. Well, if we look at new products we've added, the Imagyst platform, we're excited with its first indication obviously in fecal, that's the AI powered one. We're looking for additional indications there.
So the last piece there would also be reference labs. So we're continuing to expand our U.S. reference lab probably adding about three to five more labs this year. So we believe diagnostics is a core part of our portfolio. It's a market that grows at 10% plus. We're really pleased that we're starting to see some strong momentum across the different parts of it. So both reference lab as well as placements, as well as consumables.
So we remain very committed to the space and are pleased with our progress over them.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
Thank you, Brock.

    Prediction (one of UP, DOWN, SAME): SAME
You are a financial analyst, determining what effect an earnings call will have on the company's stock price, based on a summary of one. Be as critical and skeptical as possible, and remember that the market may disproportionally react to small unexpected details. Respond with one of: UP, DOWN, SAME
 
It will be second half of the year, third, fourth quarter.

    Prediction (one of UP, DOWN, SAME): SAME